{
    "nctId": "NCT03787966",
    "briefTitle": "Attenuating Cancer Treatment-related Toxicity in Oncology Patients With a Tailored Physical Exercise Program",
    "officialTitle": "Attenuating Cancer Treatment-related Toxicity in Oncology Patients With a Tailored Physical Exercise Program: Study Protocol of the ATOPE Trial in Women Recently Diagnosed With Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 110,
    "primaryOutcomeMeasure": "Left ventricular ejection fraction",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* 18 years or older\n* Breast cancer diagnosis I-III stage\n* On the waiting list to anticancer medical treatment (at least surgery, chemotherapy and radiotherapy.\n* If they meet other criteria which predisposes to higher toxicity.\n* Have signed informed consent.\n* Have medical clearance for participation.\n\nExclusion Criteria:\n\n* Patient underwent previous cancer treatments.\n* Patients were previously diagnosed with cancer.\n* Pregnant patients.\n* Patients performing other type of therapeutic exercise at diagnosis time with an intake \\>or = to 150 moderate-intensity or 75 min of vigorous-intensity a day.\n* Therapeutic exercise practice not recommended because psychiatric or cognitive disorders or cute or chronic condition that prevents exercise (advanced lung disease, oxygen requirement, stenosis \\>70%, metastasis etc.).",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}